Squarepoint’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.25M Sell
108,200
-585,800
-84% -$13.8M ﹤0.01% 2099
2025
Q4
$22.5M Sell
694,000
-81,800
-11% -$3.5M 0.02% 690
2025
Q3
$44M Sell
775,800
-905,500
-54% -$46.4M 0.04% 446
2025
Q2
$83.8M Buy
1,681,300
+1,369,100
+439% +$61.9M 0.09% 251
2025
Q1
$9.23M Buy
312,200
+45,800
+17% +$1.7M 0.01% 1065
2024
Q4
$6.44M Buy
+266,400
New +$6.6M 0.01% 1444
2024
Q3
Sell
-10,200
Closed -$206K 4340
2024
Q2
$206K Buy
+10,200
New +$170K ﹤0.01% 3640

Other funds holding HIMS

Squarepoint's HIMS Position: Q1 2026 in Review

Squarepoint reduced its Hims & Hers Health (HIMS) stake by 91% in Q1 2026, selling an estimated $6.29M and leaving 26,948 shares worth $559K. The position accounts for ﹤0.01% of the portfolio, ranked #3247.

Squarepoint first reported a position in HIMS in Q1 2021 and has held it in 17 quarters since. The position peaked at $57.9M in Q2 2025. 434 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

  • Squarepoint held 26,948 shares of Hims & Hers Health worth $559K as of Q1 2026.
  • Squarepoint sold 266,155 Hims & Hers Health shares in Q1 2026, an estimated $6.29M.
  • Hims & Hers Health made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #3247 holding.
  • Squarepoint first reported a position in Hims & Hers Health in Q1 2021 and has held it in 17 quarters since.
  • Squarepoint's Hims & Hers Health position peaked at $57.9M in Q2 2025.
  • 434 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.